AVX701

BIOLOGICAL2 trials

Sponsors

AlphaVax, Inc., Duke University

Conditions

Breast CancerColon CancerColorectal CancerLung CancerPancreatic CancerStage III Colon Cancer

Phase 1

A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies

CompletedNCT00529984

AlphaVax, Inc.Breast Cancer, Colon Cancer, Colorectal Cancer +2

Start: 2007-09-30End: 2010-05-31Updated: 2012-07-12

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

CompletedNCT01890213

Duke UniversityStage III Colon Cancer

Start: 2013-11-30End: 2019-07-31Target: 12Updated: 2019-07-18